- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Hikal is a partner to companies in the Pharmaceuticals, Crop Protection, and Specialty Chemicals industry. The company is in the business of supplying research services, active ingredients and intermediates for its customers. Hikal's manufacturing facilities have been inspected and approved by leading multinational companies in the Crop protection and Pharmaceutical sectors. The Crop protection facilities are located at Taloja and Mahad {Maharashtra). The Pharmaceutical manufacturing facilities are situated in Jigani (Bengaluru) and Panoli (Gujarat). Hikal's R & D facilities are located in Pune.
Hikal Ltd. will host an in-person Group Meeting for Analysts and Institutional Investors at its Pune R&T centre on September 04, 2026, from 12:00 P.M. onwards. Participants will interact with company officials, with discussions based on publicly available information.
Hikal's full-year results show a loss of 48.7 Cr on revenue of 1,712.6 Cr due to headwinds and exceptional charges. Operational recovery is underway, boosting optimism. The company commissioned new HPAPI and Kilo labs, launched a Personal Care facility, and proposed Sameer Hiremath as Chairman & MD.